Correlation Between DexCom and Sanara Medtech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both DexCom and Sanara Medtech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DexCom and Sanara Medtech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DexCom Inc and Sanara Medtech, you can compare the effects of market volatilities on DexCom and Sanara Medtech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DexCom with a short position of Sanara Medtech. Check out your portfolio center. Please also check ongoing floating volatility patterns of DexCom and Sanara Medtech.

Diversification Opportunities for DexCom and Sanara Medtech

0.26
  Correlation Coefficient

Modest diversification

The 3 months correlation between DexCom and Sanara is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding DexCom Inc and Sanara Medtech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sanara Medtech and DexCom is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DexCom Inc are associated (or correlated) with Sanara Medtech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sanara Medtech has no effect on the direction of DexCom i.e., DexCom and Sanara Medtech go up and down completely randomly.

Pair Corralation between DexCom and Sanara Medtech

Given the investment horizon of 90 days DexCom Inc is expected to under-perform the Sanara Medtech. In addition to that, DexCom is 1.02 times more volatile than Sanara Medtech. It trades about -0.03 of its total potential returns per unit of risk. Sanara Medtech is currently generating about 0.0 per unit of volatility. If you would invest  3,650  in Sanara Medtech on December 4, 2024 and sell it today you would lose (368.00) from holding Sanara Medtech or give up 10.08% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

DexCom Inc  vs.  Sanara Medtech

 Performance 
       Timeline  
DexCom Inc 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in DexCom Inc are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating fundamental indicators, DexCom may actually be approaching a critical reversion point that can send shares even higher in April 2025.
Sanara Medtech 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Sanara Medtech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

DexCom and Sanara Medtech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with DexCom and Sanara Medtech

The main advantage of trading using opposite DexCom and Sanara Medtech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DexCom position performs unexpectedly, Sanara Medtech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sanara Medtech will offset losses from the drop in Sanara Medtech's long position.
The idea behind DexCom Inc and Sanara Medtech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency